STOCK TITAN

PACS Group insider plans $6.4M stock sale

Form 144 shows Mark Hancock planning potential secondary sales of PACS Group, Inc. common stock, with prior sales detailed over the past three months.

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) is named as the issuer in a Form 144 filing by Mark Hancock covering proposed sales of its common stock. The notice lists up to 144,318 shares of PACS common stock to be sold through Citigroup Global Markets Inc. on the NYSE, with an aggregate market value of $6,432,859.40 as of September 14, 2026.

The filing states that Hancock originally acquired 54,626,199 shares at the formation of the issuer on March 1, 2023 for cash, and details multiple prior sales of PACS common stock over the three months from June 15, 2026 to July 15, 2026, each with specified share counts and dollar amounts.

Positive

  • None.

Negative

  • None.
Shares covered by Form 144 144,318 shares Common stock proposed to be sold through Citigroup Global Markets Inc.
Aggregate market value of shares covered $6,432,859.40 Value of 144,318 PACS common shares as of September 14, 2026
Shares acquired at formation 54,626,199 shares PACS common stock acquired by Mark Hancock on March 1, 2023 for cash
Sale on June 15, 2026 153,254 shares for $5,568,759.95 PACS common stock sold by Mark Hancock during past three months
Sale on June 16, 2026 83,066 shares for $2,982,385.05 PACS common stock sold by Mark Hancock during past three months
Sale on July 6, 2026 142,163 shares for $6,444,860.09 PACS common stock sold by Mark Hancock during past three months
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
aggregate market value financial
"144318 | 6432859.40 | 158191294 | 09/14/2026 | NYSE"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Securities To Be Sold financial
"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for PACS Group, Inc. (PACS)?

It discloses that Mark Hancock has filed a notice under Rule 144 for the potential sale of PACS Group, Inc. common stock, specifying the number of shares covered, their aggregate market value, prior sales, and the broker to be used.

How many PACS (PACS) shares does the Form 144 say may be sold?

The filing covers the potential sale of up to 144,318 shares of PACS Group, Inc. common stock, to be sold through Citigroup Global Markets Inc. on the NYSE, as stated in the securities information section.

What aggregate market value is reported for the PACS shares in this Form 144?

The Form 144 reports an aggregate market value of $6,432,859.40 for the 144,318 shares of PACS Group, Inc. common stock covered by the notice, with the valuation dated September 14, 2026.

What prior ownership of PACS (PACS) shares does Mark Hancock report?

Mark Hancock reports acquiring 54,626,199 shares of PACS Group, Inc. common stock on March 1, 2023, described as shares acquired at formation of the issuer for cash.

What recent PACS share sales by Mark Hancock are listed in the Form 144?

The notice lists multiple sales of PACS common stock from June 15, 2026 to July 15, 2026, including transactions such as 153,254 shares for $5,568,759.95 on June 15, 2026 and other specified share and dollar amounts on subsequent dates.

Which broker is named for the PACS (PACS) stock sales in this Form 144?

The broker named is Citigroup Global Markets Inc., located in New York, which is listed in connection with the 144,318 shares of PACS Group, Inc. common stock to be sold on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading